However, our study revealed that there was no significant difference in the levels of IL-6,TNF-α between the MDD group at baseline and after treatment and post-treatment IL-6 and TNF-α levels in the MDD group remained higher than in the HC group, diverging from prior study outcomes (47, 48). This evidence concerns the gene IL6 and major depressive disorder.